Publicaciones en colaboración con investigadoras/es de Hospital de Cruces (18)

2024

  1. Negative symptoms and sex differences in first episode schizophrenia: What's their role in the functional outcome? A longitudinal study

    Spanish Journal of Psychiatry and Mental Health

2023

  1. Psychosis and substance abuse increase the COVID-19 mortality risk

    Psychological Medicine, Vol. 53, Núm. 9, pp. 4236-4244

  2. Traumatic stress symptoms among Spanish healthcare workers during the COVID-19 pandemic: a prospective study

    Epidemiology and psychiatric sciences, Vol. 32, pp. e50

2022

  1. Mental impact of Covid-19 among Spanish healthcare workers. A large longitudinal survey

    Epidemiology and Psychiatric Sciences, Vol. 31

2021

  1. Cognitive Enhancers in Schizophrenia: A Systematic Review and Meta-Analysis of Alpha-7 Nicotinic Acetylcholine Receptor Agonists for Cognitive Deficits and Negative Symptoms

    Frontiers in Psychiatry, Vol. 12

  2. Gender-Based Analysis of the Psychological Impact of the COVID-19 Pandemic on Healthcare Workers in Spain

    Frontiers in Psychiatry, Vol. 12

  3. Mental health impact of the first wave of COVID-19 pandemic on Spanish healthcare workers: A large cross-sectional survey

    Revista de Psiquiatria y Salud Mental, Vol. 14, Núm. 2, pp. 90-105

  4. Thirty-day suicidal thoughts and behaviors among hospital workers during the first wave of the Spain COVID-19 outbreak

    Depression and Anxiety, Vol. 38, Núm. 5, pp. 528-544

  5. Thirty-day suicidal thoughts and behaviours in the Spanish adult general population during the first wave of the Spain COVID-19 pandemic

    Epidemiology and Psychiatric Sciences, Vol. 30

2020

  1. Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study

    Schizophrenia Research, Vol. 218, pp. 292-294

2019

  1. A systematic review of sex-based differences in effectiveness and adverse effects of clozapine

    Psychiatry Research, Vol. 280

2018

  1. Smoking does not impact social and non-social cognition in patients with first episode psychosis

    Schizophrenia Research, Vol. 199, pp. 64-74

  2. Therapeutic Drug Monitoring of Second-Generation Antipsychotics for the Estimation of Early Drug Effect in First-Episode Psychosis: A Cross-sectional Assessment

    Therapeutic Drug Monitoring, Vol. 40, Núm. 2, pp. 257-267

2017

  1. A Pilot Study of the Usefulness of a Single Olanzapine Plasma Concentration as an Indicator of Early Drug Effect in a Small Sample of First-Episode Psychosis Patients

    Journal of Clinical Psychopharmacology, Vol. 37, Núm. 5, pp. 569-577

  2. Intuitive pharmacogenetic dosing of risperidone according to CYP2D6 phenotype extrapolated from genotype in a cohort of first episode psychosis patients

    European Neuropsychopharmacology, Vol. 27, Núm. 7, pp. 647-656

2008

  1. Curso del funcionamiento cognitivo en primeros episodios psicóticos: estudio comparativo entre esquizofrenia y otros diagnósticos psicóticos

    Revista de Psiquiatria y Salud Mental, Vol. 1, Núm. 1, pp. 18-25

2002

  1. Tratamiento precoz con risperidona de primeros episodios psicóticos: Dos años de seguimiento

    Actas Espanolas de Psiquiatria, Vol. 30, Núm. 3, pp. 142-152

2000

  1. Hospitalización contra la voluntad en primeros episodios psicóticos: Factores asociados

    Actas Espanolas de Psiquiatria, Vol. 28, Núm. 5, pp. 275-278